Anne Nunes - Jun 19, 2023 Form 3/A Insider Report for Anika Therapeutics, Inc. (ANIK)

Role
SVP, Chief Operations Officer
Signature
/s/ Anne Nunes
Stock symbol
ANIK
Transactions as of
Jun 19, 2023
Transactions value $
$0
Form type
3/A
Date filed
1/12/2024, 04:35 PM
Date Of Original Report
Jun 26, 2023
Next filing
Oct 3, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding ANIK Common Stock 4.78K Jun 19, 2023 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This Form 3 amendment is being filed solely to correct the original Form 3 filed on June 26, 2023. The Amount of Securities Beneficially Owned under Table I, Column 2 was incorrectly reported as 3,293 shares in the original Form 3, and affected the reported amount in subsequent Form 4 filings.